Showing 1,701 - 1,720 results of 9,650 for search 'significant ((((gap decrease) OR (((greater decrease) OR (we decrease))))) OR (mean decrease))', query time: 0.66s Refine Results
  1. 1701

    Data for Figs 8A–8H, 9A–9K, 10A–10I. by Xiaohua Zhang (350570)

    Published 2024
    “…In <i>vivo</i> experiments further showed that PRV UL4 (<sup>132</sup>DVAADAAAEAAAAE<sup>145</sup>) mutated strain (PRV-UL4<sup>mut</sup>) infection did not lead to a significant decrease in viral titers at 12 h. p. i, but it induced lower levels of IL-1β, IL-18, and GSDMD-NT, which led to an alleviated inflammatory infiltration and pathological damage in the lungs and brains, and a lower death rate compared with wild-type PRV strain infection. …”
  2. 1702

    Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  3. 1703

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  4. 1704

    Store listing metrics and user acquisition. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  5. 1705

    Installation, growth, and retention metrics. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  6. 1706

    Implemented activities. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  7. 1707

    App user retention trends. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  8. 1708

    App user onboarding trends. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  9. 1709

    App user base growth trends. by Henri Claude Moungui (22227043)

    Published 2025
    “…Interrupted time series analyses found gradual adoption and sustained retention following intervention start, but significant decrease at campaign end.</p><p>Conclusion</p><p>A context‑adapted, multi‑channel marketing strategy markedly improved adoption and retention of the WHO SkinNTDs app among Cameroonian FHWs. …”
  10. 1710
  11. 1711

    <i>SLC2A2</i> is essential for liver differentiation in developing vertebrates by Yejin Kim (740789)

    Published 2025
    “…Data are represented as mean ± standard error of the mean (SEM). (G) Quantitative RT-PCR analysis was performed to evaluate the expression levels of igf1r. …”
  12. 1712

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  13. 1713

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  14. 1714

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  15. 1715

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
  16. 1716

    Primer sequences for RT-qPCR. by Wenlong Shen (9313937)

    Published 2025
    “…Data from TCGA showed that NCOA4 shows greater downgrade in tumor tissues than in non-tumor tissues and the overall survival (OS) of patients with low NCOA4 expression was significantly shorter than that of patients with high NCOA4 expression.The qPCR results showed that NCOA4 was expressed at low levels in cholangiocarcinoma tissue specimens; the mRNA expression of NCOA4 decreased after knocking down NCOA4 in cells. …”
  17. 1717

    siRNA sequences and negative controls sequences. by Wenlong Shen (9313937)

    Published 2025
    “…Data from TCGA showed that NCOA4 shows greater downgrade in tumor tissues than in non-tumor tissues and the overall survival (OS) of patients with low NCOA4 expression was significantly shorter than that of patients with high NCOA4 expression.The qPCR results showed that NCOA4 was expressed at low levels in cholangiocarcinoma tissue specimens; the mRNA expression of NCOA4 decreased after knocking down NCOA4 in cells. …”
  18. 1718

    Antibodies used in the study. by Wenlong Shen (9313937)

    Published 2025
    “…Data from TCGA showed that NCOA4 shows greater downgrade in tumor tissues than in non-tumor tissues and the overall survival (OS) of patients with low NCOA4 expression was significantly shorter than that of patients with high NCOA4 expression.The qPCR results showed that NCOA4 was expressed at low levels in cholangiocarcinoma tissue specimens; the mRNA expression of NCOA4 decreased after knocking down NCOA4 in cells. …”
  19. 1719
  20. 1720